Psychedelic Drug Library Earns Psilera U.S. Patent

The company formulates synthetic psychedelic compounds for mental health treatments.

Tampa-based biopharmaceutical company Psilera received a notice of allowance from the U.S. Patent and Trademark Office for its patent application on new mental health treatments for home use.

The patent provides protections for the company’s expansive drug library, it said, resulting from “years of dedicated research and development to curate a diverse collection of compounds with disease modifying potential for mental health disorders,” the company said in a statement Wednesday.

CEO Chris Witowski said the approval represents “one of the most significant IP allowances of a next-generation psychedelic compound library.”

He added, “Securing this patent is not just a legal milestone; it’s a testament to our relentless pursuit of innovation and our commitment to shaping a brighter future for patients with unmet needs.”

Studies indicate that Psilera’s drug candidates have quick efficacy for various psychiatric and addiction disorders, the company said.

“Furthermore, Psilera has de-risked multiple drug classes in this IP allowance which have shown improved safety profiles and fewer side effects than current psychedelics,” it added.

The patent follows Psilera’s prior milestone related to formulas for dimethyltryptamine (DMT) and a psilocybin-like drug, psilacetin. The company said it aims to create therapies that limit hallucinogenic effects to cater to a broader patient base.

Adam Jackson

Adam Jackson writes about the cannabis industry for the Green Market Report. He previously covered the Missouri Statehouse for the Columbia Missourian and has written for the Missouri Independent. He most recently covered retail, restaurants and other consumer companies for Bloomberg Business News. You can find him on Twitter at @adam_sjackson and email him at

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.